ArticleAntibiotics (Basel, Switzerland)2021
Mortality Following
Registry-linked trialOpen access · goldAbstract read
In one paragraph
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05447533 (Frail Old Patients With Clostridioides Difficile Infection), which is not on this map. Cited by 32 papers.
0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Frail Old Patients With Clostridioides Difficile Infection: Improvement of Quality in Treatment and Care
Who cites it
32 citing papers in PubMed, 51 citations in OpenAlex.
- Influence of COVID-19 on Clinical Outcomes ofAntibiotics (Basel, Switzerland) · 2026Article
- Biomarkers for Early Severity Prediction inMedicina (Kaunas, Lithuania) · 2026Review
- Article
- Incidence of hospital-acquired toxin-producing clostridioides difficile infection between the pre-pandemic (2017-2019) and pandemic (2020-2022): a retrospective cohort study.Archives of public health = Archives belges de sante publique · 2026Article
- Burden ofAntibiotics (Basel, Switzerland) · 2025Article
- Challenges and Strategies in Managing RecurrentGeriatrics (Basel, Switzerland) · 2025Article
- Association of antimicrobial consumption withInfection prevention in practice · 2025Article
- Discordance in Clinical Indicators With Sequential Fecal Microbiota Transplantation: A Case of FulminantACG case reports journal · 2025Article
- In vitro validation concept for lyophilized fecal microbiota products with a focus on bacterial viability.World journal of microbiology & biotechnology · 2025Article
- Bioinformatic and experimental identification and characterization ofFrontiers in immunology · 2025Article
- [Clostridiodes difficile bacteraemia. First mexican case report].Revista medica del Instituto Mexicano del Seguro Social · 2024Article
- Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.Infectious diseases and therapy · 2024Article
- Article
- Prevalence of Enteric Pathogens and Antibiotic Resistance: Results of a Six-Year Active Surveillance Study on Patients Admitted to a Teaching Hospital.Antibiotics (Basel, Switzerland) · 2024Article
- Introduction to the Special Issue onAntibiotics (Basel, Switzerland) · 2024Article
- Mortality in clostridioides difficile infection among patients hospitalized at the university clinical hospital in Wroclaw, Poland - a 3-year observational study.BMC infectious diseases · 2024Observational
- Epidemiological and clinical burden of Clostridioides difficile infections and recurrences between 2015 - 2019: the RECUR Germany study.BMC infectious diseases · 2024Observational
- A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure andAntibiotics (Basel, Switzerland) · 2024Article
- Interaction of Clostridioides difficile infection with frailty and cognition in the elderly: a narrative review.European journal of medical research · 2023Review
- High Prevalence ofPathogens (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 13 institutions in 9 countries.
Jacek CzepielDepartment of Infectious and Tropical Diseases, Jagiellonian University Medical College, 30-688 Krakow, Poland.ORCID 0000-0002-9997-8417
Marcela KrutovaDepartment of Medical Microbiology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, 15006 Prague, Czech Republic.
Assaf MizrahiESCMID Study Group for Clostridioides Difficile (ESGCD), 4001 Basel, Switzerland.ORCID 0000-0003-3135-5093
Nagham KhanaferESCMID Study Group for Clostridioides Difficile (ESGCD), 4001 Basel, Switzerland.
David A EnochClinical Microbiology & Public Health Laboratory, Public Health England, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
Márta PatyiHygienic Department, Bács-Kiskun County Teaching Hospital, 6000 Bács-Kiskun, Hungary.
Aleksander DeptułaDepartment of Propaedeutics of Medicine and Infection Prevention, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Antonella AgodiDepartment of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123 Catania, Italy.ORCID 0000-0002-4405-8162
Xavier NuvialsCritical Care Department, Vall d'Hebron Hospital, Vall d'Hebron Institut de Recerca (VHIR), SODIR Group, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-6648-2394
Hanna PituchESCMID Study Group for Clostridioides Difficile (ESGCD), 4001 Basel, Switzerland.ORCID 0000-0002-2348-4402
Małgorzata Wójcik-BugajskaDepartment of Internal and Geriatric Diseases, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Iwona Filipczak-BryniarskaDepartment of Pain Treatment and Palliative Care, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Bartosz BrzozowskiDepartment of Gastroenterology and Hepatology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Marcin KrzanowskiDepartment of Nephrology and Dialysis Unit, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Katarzyna KonturekIntensive Care Unit, University Hospital, 30-688 Krakow, Poland.
Marcin FedewiczJózef Babiński Hospital, 30-393 Krakow, Poland.
Mateusz MichalakLudwik Rydygier Hospital, 31-826 Krakow, Poland.
Lorra MonpierreService de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, 75014 Paris, France.
Philippe VanhemsUnité d'Hygiène, Epidémiologie et Prévention, Groupement Hospitalier Centre, Hospices Civils de Lyon, 69002 Lyon, France.
Theodore GouliourisClinical Microbiology & Public Health Laboratory, Public Health England, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
Artur JurczyszynDepartment of Hematology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Sarah Goldman-MazurDepartment of Hematology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Dorota WultańskaDepartment of Medical Microbiology, Medical University of Warsaw, 02-004 Warsaw, Poland.ORCID 0000-0003-4694-9353
Ed J KuijperESCMID Study Group for Clostridioides Difficile (ESGCD), 4001 Basel, Switzerland.
Jan SkupieńDepartment of Metabolic Diseases, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Grażyna BiesiadaDepartment of Infectious and Tropical Diseases, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Aleksander GarlickiDepartment of Infectious and Tropical Diseases, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Jagiellonian University · PLMedical University of Warsaw · PLPublic Health England · GBUniversité Claude Bernard Lyon 1 · FRAgroParisTech · FRBács-Kiskun Megyei Kórház · HUCharles University · CZHôpital Paris Saint-Joseph · FRKrakow Cardiovascular Research Institute · PLLeiden University Medical Center · NLNicolaus Copernicus University · PLUniversitat Autònoma de Barcelona · ESUniversity of Catania · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to describe the clinical presentation, treatment, outcome and report on factors associated with mortality over a 90-day period in
Indexed as
Clostridioides difficile infectionco–morbiditiesmalignancymortalityoutcomerisk factors
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT05447533ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.